Epstein Becker & Green

Today, I’m bringing you a post from an ILN marketer, Amanda Schneider. Amanda is with ILN member firm Epstein Becker Green, where she is the Chief Marketing Officer. Amanda provides tips on how firms can leverage the multigenerational attorney workforce through involvement in business development initiatives.

***

It is critical for firms to understand that attorney engagement in business and client development must begin in the early stages of an attorney’s career to ensure that he or she is prepared for the prospect of partnership. However, in order to do this, the firm’s culture must be accepting of providing true business development opportunities to non-partner attorneys.
Continue Reading How to Leverage Multigenerational Talent to Achieve Business Development Success

Following Doug’s comments on the case for payment and delivery reform in the United States, Stuart Gerson was next to the podium to discuss whether the mandate is constitutional. 

Stuart began by saying that it’s important to understand one thing – this discussion, besides the quality and efficiency issues, is about health insurance and not about healthcare itself. This is one of the real pitfalls of the US system – we provide healthcare to almost everyone, but it’s done through a series of cost-shifting and inefficiencies, and that’s what these programs are trying to address. 

He added that he hoped to make his presentation interesting for non-Americans, many of whom live in systems with national health programs supplemented by private insurance. These countries feel that they have all the answers, and in some senses they do, with many of the countries providing a reasonable quality of healthcare at a vastly lower percentage of the GDP than what the US is doing. Although the US has some high end medicine, we also have a lot of inefficiency. 


Continue Reading Is the Mandate Constitutional – US National Health Care Act – a Presentation by Stuart Gerson

Rumor has it that SCOTUS might announce their decision on the PPACA today, so there’s no more appropriate time to continue our discussion of health care reform! Today, I’m bringing you a recap of Doug Hasting’s presentation during the ILN’s 24th Annual Meeting in Washington, DC. 

Doug said he would touch a little bit on the context that the health reform law provides or relates to in connection with the way that the healthcare delivery system in the US is evolving. He said that there are interesting interconnections there that lead into implications for how the Supreme Court ruling, whichever way it comes down, might affect that system. 

The healthcare delivery system – doctors, hospitals, long-term healthcare companies, laboratories – in the US is overwhelmingly private. There is a little bit of veterans’ care, and some state universities have partial relationships with university medical centers, but otherwise, it’s overwhelmingly private. From a payment standpoint, it’s about 50% private, but when you add in all of the different components of Federal and state payment (Medicare, Medicaid, etc.), there is still a significant amount of private health plans paying for healthcare. 


Continue Reading The Case for Payment and Delivery Reform in the US – A Presentation from Doug Hastings

During our 2012 Annual Meeting in May, we were fortunate to have an excellent presentation from a panel of health care law experts from Epstein Becker & Green. First up, we had Lynn Shapiro Snyder, who spoke about health reform at the federal and state levels, as well as private parties achieving health reform. 

Lynn has a long background in the healthcare field, and has been with Epstein Becker & Green almost since it was founded. She began by saying that many people think of "healthcare" as being about doctors and hospitals. But it’s also pharmaceutical companies, private equity firms, and banks – because, for all of us, healthcare and life sciences represent such a major portion of our economy. 


Continue Reading Overview of Health Reform Activities in the US – A Presentation from Lynn Shapiro Snyder

Yesterday, I shared with you this post re-capping Alishan Naqvee’s introduction to the topic of anti-corruption at our 2011 Annual Meeting.  To follow up on that, we’ll review Stuart Gerson’s (Epstein Becker & Green) comments during the session regarding the Foreign Corrupt Practices Act (FCPA) and its implications for those in the room.  

Stuart provided the attendees with both an article he and a colleague authored on the FCPA, and an overview that their healthcare group had developed.  Stuart said that as Alishan had mentioned, both the FCPA and the new UK Anti-Bribery law are extraterritorial – but not only are they applied overseas throughout the world, but they are also applied against non-US citizens, as long as the commerce that they’re supporting is in the stream of interstate commerce within the US.

So non-US citizens who have never stepped food in the US are subject to the FCPA, which is a criminal statute that has long jail sentences associated with it.  Additionally, they have fines up to $2 million per offense – and an offense is an individual act, so there could be a long series of them that results in the fines adding up to immense sums.  And this is applicable all around the world.


Continue Reading Corporate Breakout Session – Anti-Corruption Laws – the FCPA

Welcome to ILN-terviews, a series of profiles of ILN member firm attorneys, designed to give a unique insight into the lawyers who make up our Network. For our latest interview, we chose ILN member, Stuart Gerson of Epstein Becker & Green, P.C. in Washington, D.C.

In one sentence, how would you describe your practice?
Representing